| Table 3. Analysis of difference between MII, MI and GV scores between the antagonist and dydrogesterone groups. | |||||||
| Variable | Group | M (CI) | SD(CI) | gl | F | p | x |
|---|---|---|---|---|---|---|---|
| M II | Antagonist | 6.28 (5.48 -7.14) | 4.72 (3.95 - 5.42) | 1, 289 | 2.12 | 0.15 | 0.007 |
| Dydrog | 6.71 (6.00 - 7.48) | 4.53 (3.87 - 5.11) | |||||
| VG | Antagonist | 1.62 (1.25 - 2.02) | 2..28 (1.75 - 2.72) | 1, 250 | 0.12 | 0.73 | 0.001 |
| Dydrog | 1.40 (1.04 - 1.79) | 2.23 (1.68 - 2.69) | |||||
| MI | Antagonist | 0.62 (0.44 - 0.83) | 1.30 (0.75 - 1.76) | 1, 251 | 0.25 | 0.61 | 0.001 |
| Dydrog | 0.47 (0.31 - 0.66) | 1.07 (0.62 - 1.53) | |||||
SD= standard deviation; Ave = average; gl = degree of freedom; p = statistical significance; η 2 = partial squared Eta.
Control variables: age, AMH, AFC and BMI.